Transient ischemic attack Clinical Trials
Conditions / Transient ischemic attack
Delta Trials indexes 158 clinical trials for Transient ischemic attack in its publicly accessible dataset. Of these, 16 enrolling participants at this time and 92 trials have reached completion. This research takes place spanning 504 research sites around the world. An additional 50 trials are in preparatory or other active non-recruiting stages. Since 2020, 6 trials were terminated, illustrating the dynamic nature of clinical research. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.
Trial Status
158
Total Trials
16
Recruiting
92
Completed
50
Other Active
6
Terminated since 2020
504
Study Locations
Browse by location (504 total)
- Beijing, China 16 trialsAll trials in Beijing, China
- Toronto, Canada 10 trialsAll trials in Toronto, Canada
- New York, United States 9 trialsAll trials in New York, United States
- Edmonton, Canada 7 trialsAll trials in Edmonton, Canada
- Shanghai, China 7 trialsAll trials in Shanghai, China
- London, Canada 6 trialsAll trials in London, Canada
- Vancouver, Canada 6 trialsAll trials in Vancouver, Canada
- Chongqing, China 6 trialsAll trials in Chongqing, China
- Jinan, China 5 trialsAll trials in Jinan, China
- Tianjin, China 5 trialsAll trials in Tianjin, China
- Wuhan, China 5 trialsAll trials in Wuhan, China
- Zhengzhou, China 5 trialsAll trials in Zhengzhou, China
- Indianapolis, United States 5 trialsAll trials in Indianapolis, United States
- Seoul, South Korea 5 trialsAll trials in Seoul, South Korea
- Shijiazhuang, China 5 trialsAll trials in Shijiazhuang, China
- Nanjing, China 5 trialsAll trials in Nanjing, China
- Shenyang, China 5 trialsAll trials in Shenyang, China
- Jinan, China 5 trialsAll trials in Jinan, China
- Guangzhou, China 5 trialsAll trials in Guangzhou, China
- Montréal, Canada 4 trialsAll trials in Montréal, Canada